Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
14:28:39 EST Wed 04 Dec 2024
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

V:NRX - NurExone Biologic Inc. - http://www.nurexone.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NRX - V  2.50.71·0.7215.50.716.2480.71  0.71  0.711.19  0.2610:44:11Nov 2715 min RT 2¢
TSX-V - V2.50.71·0.7215.50.715.9470.71  0.71  0.711.19  0.2610:44:1115 min
TriAct - M 0.710.301    15 min

Recent Trades - All 8 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
10:44:49M0.720.013001 Anonymous2 RBCE
10:44:11V0.71 20039 Merrill Lynch36 Latimer
10:44:11V0.71 3,00039 Merrill Lynch88 CredentialK
10:44:11V0.71 50039 Merrill Lynch1 AnonymousK
09:30:00V0.71 4007 TD Sec36 Latimer
09:30:00V0.71 5007 TD Sec1 AnonymousKL
09:30:00V0.71 1,0007 TD Sec33 CanaccordKL
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-11-27 07:11C:NRX0.70SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-11-27 07:11C:NRX0.70SEDAR Interim MD & ASEDAR Interim MD & A
2024-11-27 07:01C:NRX0.70News ReleaseNurExone Reports Third Quarter 2024 Financial Results and Provides Corporate Update
2024-11-13 16:28C:NRX0.63News ReleaseNurexone's ExoPTEN therapy receives EMA orphan status
2024-11-12 19:56C:NRX0.60Private PlacementNurexone Biologic 3,159,359-share private placement
2024-11-01 17:04C:NRX0.67News ReleaseNurexone closes final tranche of placement
2024-09-26 18:08C:NRX0.57News ReleaseNurexone closes $1.61M first tranche of financing
2024-09-06 16:48C:NRX0.56News ReleaseNurexone finds one-week window for ExoPTEN use
2024-08-28 19:06C:NRX0.63News ReleaseNurexone spends $510,000 (U.S.) on R&D in Q2 2024
2024-08-28 14:41C:NRX0.65SEDAR Annual Information FormSEDAR Annual Information Form
2024-08-27 17:18C:NRX0.65SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-08-27 17:18C:NRX0.65SEDAR Interim MD & ASEDAR Interim MD & A
2024-08-15 17:37C:NRX0.59News ReleaseNurexone talks exosome manufacturing process
2024-08-09 16:19C:NRX0.59News ReleaseNurexone's ExoPTEN shows homing capacity in study
2024-08-01 17:20C:NRX0.64News ReleaseNurexone transfers tech to GMP-compliant vendor
2024-07-29 16:04C:NRX0.61News ReleaseNurExone Announces Further Expansion of ExoPTEN Patent Coverage
2024-07-17 19:46C:NRX0.69News ReleaseNurexone receives preliminary results of ExoPTEN study
2024-07-05 08:43C:NRX0.69News ReleaseUpdates from NurExone: Growth Conference Presentation and Website Relaunch
2024-06-28 16:46C:NRX0.66News ReleaseNurexone's Exopten to go through preclinical study
2024-06-21 16:27C:NRX0.62News ReleaseNurexone appoints Geffen as consultant